NDC 49702-248

Vocabria

Cabotegravir Sodium

Vocabria is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Cabotegravir Sodium.

Product ID49702-248_65b02f5b-063a-4832-b1ec-ada39ea0e66e
NDC49702-248
Product TypeHuman Prescription Drug
Proprietary NameVocabria
Generic NameCabotegravir Sodium
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-01-21
Marketing CategoryNDA / NDA
Application NumberNDA212887
Labeler NameViiV Healthcare Company
Substance NameCABOTEGRAVIR SODIUM
Active Ingredient Strength30 mg/1
Pharm ClassesHIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Organic Anion Transporter 1 Inhibitors [MoA], Organic Anion Transporter 3 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 49702-248-13

30 TABLET, FILM COATED in 1 BOTTLE (49702-248-13)
Marketing Start Date2021-01-21
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [Vocabria]

Mark Image

Registration | Serial
Company
Trademark
Application Date
VOCABRIA
VOCABRIA
87420842 5335230 Live/Registered
ViiV Healthcare UK (No.3) Limited
2017-04-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.